LifeMD (LFMDP) Competitors $25.06 +0.17 (+0.68%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock LFMDP vs. ACONW, AONC, DHACW, OTRKP, PIIIW, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. LifeMD vs. Aclarion American Oncology Network Digital Health Acquisition Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health LifeMD (NASDAQ:LFMDP) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, community ranking, earnings, risk, media sentiment, analyst recommendations and institutional ownership. Does the media refer more to LFMDP or ACONW? In the previous week, LifeMD had 1 more articles in the media than Aclarion. MarketBeat recorded 5 mentions for LifeMD and 4 mentions for Aclarion. Aclarion's average media sentiment score of 0.63 beat LifeMD's score of 0.38 indicating that Aclarion is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aclarion 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor LFMDP or ACONW? LifeMD and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformLifeMDN/AN/AAclarionN/AN/A Is LFMDP or ACONW more profitable? Company Net Margins Return on Equity Return on Assets LifeMDN/A N/A N/A Aclarion N/A N/A N/A Which has preferable earnings and valuation, LFMDP or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeMD$212.45MN/AN/AN/AN/AAclarion$49.29KN/AN/AN/AN/A SummaryLifeMD beats Aclarion on 2 of the 3 factors compared between the two stocks. Remove Ads Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMDP vs. The Competition Export to ExcelMetricLifeMDHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$203.11M$5.64B$7.79BDividend Yield11.99%6.68%5.34%4.03%P/E RatioN/A239.4323.6318.68Price / SalesN/A458.51370.2189.79Price / CashN/A47.1438.1734.64Price / BookN/A5.216.744.12Net IncomeN/A-$15.55M$3.20B$247.10M7 Day Performance2.89%-0.62%-5.63%-3.81%1 Month Performance10.75%-6.57%-0.38%-6.23%1 Year Performance10.26%3.28%7.72%-1.89% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDPLifeMDN/A$25.25+1.4%N/A+8.7%$0.00$212.45M0.00230Dividend AnnouncementShort Interest ↑High Trading VolumeACONWAclarionN/A$0.04-10.1%N/A-0.3%$0.00$49,289.000.007News CoverageAONCAmerican Oncology NetworkN/A$5.25+0.6%N/A-9.5%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.04flatN/A-68.8%$0.00N/A0.00N/AOTRKPOntrakN/A$0.24+1.8%N/A-66.9%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-7.1%N/AN/A$0.00$1.48B0.00500Gap DownTALKWTalkspaceN/A$0.09-3.8%N/A-60.7%$0.00$187.59M0.00500Gap DownTOIIWOncology InstituteN/A$0.03+11.7%N/AN/A$0.00$378.93M0.00660Positive NewsNTRANatera3.8164 of 5 stars$153.83+1.8%$178.12+15.8%+57.4%$20.80B$1.70B-87.403,020Short Interest ↑Positive NewsGap DownFMSFresenius Medical Care3.197 of 5 stars$24.29+0.1%$25.30+4.2%+28.5%$14.25B$19.34B20.07123,200Positive NewsHIMSHims & Hers Health3.7624 of 5 stars$37.37+7.5%$37.31-0.2%+88.1%$8.30B$1.48B84.92650Gap Down Remove Ads Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMDP) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
